A suspected case of plasma cell-rich acute renal transplant rejection associated with de novo donor-specific antibody

作者：Yoshikawa Mikiko^*; Kitamura Ken; Ishimura Takeshi; Hara Shigeo; Fujisawa Masato; Nishi Shinichi

来源：Nephrology, 2015, 20: 66-69.

DOI：10.1111/nep.12471

• kidney transplantation
• plasma cell-rich rejection
• post-transplant lymphoproliferative disorder

A kidney transplant case with de novo donor-specific antibody showed monoclonal plasma cell infiltration into the graft with ABO incompatibility. Three years after transplantation, the patient's graft function suddenly deteriorated. Interstitial edema and the predominant infiltration of inflammatory plasma cells with kappa chain monoclonality were observed in biopsy specimens. The in situ hybridization of Epstein-Barr virus was negative and post-transplant lymphoproliferative disorder was not evident from radiological examinations. On laboratory examination, the patient had de novo donor-specific antibody for HLA-DQ. We suspected plasma cell-rich acute rejection for which methylprednisolone pulse therapy, plasma exchange, rituximab, and 15-deoxyspergualin were given. In the ensuing biopsy, the degree of plasma cell infiltration was similar to the first biopsy; however, kappa chain monoclonality relatively weakened. Owing to resistance to these treatments, intravenous immunoglobulin (IVIG) (0.5g/kg/day) was added. The serum creatinine level gradually declined to 3.1mg/dL; however, it increased up to 3.6mg/dL again. In the final biopsy, the infiltrated plasma cells disappeared but severe interstitial fibrosis developed. This case showed difficulty in the diagnosis and treatment of plasma cell-rich acute rejection. A detailed consideration of this case may be helpful in understanding the clinical features and pathogenesis of this condition.

• 出版日期2015-7